Core Laboratories provided earnings guidance for the first quarter of 2016. For the period, the company projects revenue to be $164 million and EPS between $0.41 and $0.43.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.45 USD | +2.68% | +4.74% | +21.46% |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell Small Cap Comp Value Index | CI |
Jul. 01 | Core Laboratories Inc.(NYSE:CLB) dropped from Russell 3000 Value Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.46% | 1.01B | |
0.00% | 8.92B | |
-16.06% | 2.75B | |
-19.85% | 2.45B | |
-23.49% | 1.93B | |
-14.19% | 1.02B | |
-16.81% | 951M | |
-2.70% | 736M | |
-30.24% | 649M | |
-31.50% | 608M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories Provides Earnings Guidance for the First Quarter of 2016